Cardiogenic and Myogenic Gene Expression in Mesenchymal Stem Cells After 5-Azacytidine Treatment

Objective: 5-Azacytidine is a hypomethylating agent that is used for the treatment of myelodysplastic syndrome. This histone modifier is widely employed and plays a nonspecific role in influencing the differentiation capability of stem cells. The ability of bone marrow mesenchymal stem cells to diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Supokawej, Aungkura, Kheolamai, Pakpoom, Nartprayut, Kuneerat, U-pratya, Yaowalak, Manochantr, Sirikul, Chayosumrit, Methichit, Issaragrisil, Surapol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878477/
https://www.ncbi.nlm.nih.gov/pubmed/24385773
http://dx.doi.org/10.4274/Tjh.2012.0161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878477/
https://www.ncbi.nlm.nih.gov/pubmed/24385773
http://dx.doi.org/10.4274/Tjh.2012.0161

Ejemplares similares